Holly Dushkin

824 total citations
18 papers, 455 citations indexed

About

Holly Dushkin is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Holly Dushkin has authored 18 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Genetics and 4 papers in Oncology. Recurrent topics in Holly Dushkin's work include Genetic Syndromes and Imprinting (3 papers), Breast Cancer Treatment Studies (3 papers) and Genetic and Kidney Cyst Diseases (3 papers). Holly Dushkin is often cited by papers focused on Genetic Syndromes and Imprinting (3 papers), Breast Cancer Treatment Studies (3 papers) and Genetic and Kidney Cyst Diseases (3 papers). Holly Dushkin collaborates with scholars based in United States. Holly Dushkin's co-authors include David R. Beier, Olga A. Iakoubova, Daniel J. Sussman, Robin B. Kanarek, Rodrigo Arrangoiz, Jeffrey M. Farma, Steven R. Gullans, Gino V. Segre, Richard M. Green and Tatsuya Koike and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Holly Dushkin

17 papers receiving 440 citations

Peers

Countries citing papers authored by Holly Dushkin

Since Specialization

Citations

This map shows the geographic impact of Holly Dushkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly Dushkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly Dushkin more than expected).

Fields of papers citing papers by Holly Dushkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holly Dushkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly Dushkin. The network helps show where Holly Dushkin may publish in the future.

Co-authorship network of co-authors of Holly Dushkin

This figure shows the co-authorship network connecting the top 25 collaborators of Holly Dushkin. A scholar is included among the top collaborators of Holly Dushkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holly Dushkin. Holly Dushkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Isolated secondary CNS relapse in a case of stage I diffuse large B-cell lymphoma 2014 ·BMJ Case Reports ·Yana G. Najjar, Kriti Mittal, Nadeen Faza, Holly Dushkin, David M. Peereboom	0
2	Lymphatic Space Invasion is Not an Independent Predictor of Outcomes in Early Stage Breast Cancer Treated by Breast-Conserving Surgery and Radiation 2012 ·The Breast Journal ·Gary M. Freedman, Tianyu Li, (unknown), Penny R. Anderson, Richard J. Bleicher, Elin R. Sigurdson, (unknown), Holly Dushkin, Arthur S. Patchefsky, Lori J. Goldstein	24
3	A phase I evaluation of vandetanib plus paclitaxel, carboplatin, 5-fluorouracil, and XRT induction therapy followed by surgery for previously untreated locally advanced cancer of the esophagus and GE junction. 2012 ·Journal of Clinical Oncology ·Igor Astsaturov, Joshua E. Meyer, Jonathan D. Cheng, Anthony J. Olszanski, Holly Dushkin, Adam C. Berger, (unknown), Steven J. Cohen, Barbara Burtness, Walter J. Scott	1
4	Case report and literature review: Metastatic lobular carcinoma of the breast an unusual presentation 2011 ·International Journal of Surgery Case Reports ·Rodrigo Arrangoiz, (unknown), Holly Dushkin, Jeffrey M. Farma	58
5	Inflammatory Breast Cancer 2011 ·Journal of the National Comprehensive Cancer Network ·Holly Dushkin, Massimo Cristofanilli	14
6	Impact of the Radiation Boost on Outcomes After Breast-Conserving Surgery and Radiation 2010 ·International Journal of Radiation OncologyBiologyPhysics ·Colin T. Murphy, Penny R. Anderson, Tianyu Li, Richard J. Bleicher, Elin R. Sigurdson, Lori J. Goldstein, (unknown), Crystal S. Denlinger, Holly Dushkin, Nicos Nicolaou, Gary M. Freedman	34
7	Phase II, two-arm, double-blind, multicenter, randomized study of the combination of oral WX-671 plus capecitabine versus capecitabine in first-line HER2-negative metastatic breast cancer (MBC). 2010 ·Journal of Clinical Oncology ·Lori J. Goldstein, Salomon M. Stemmer, Barbara Schmalfeldt, Nina Gottschalk, Fátima Cardoso, Holly Dushkin, C. Mala, (unknown), Paul Bevan, Nadia Harbeck	8
8	Imatinib mesylate and its potential implications for gynecologic cancers 2005 ·Current Treatment Options in Oncology ·Holly Dushkin, Russell J. Schilder	11
9	A Novel Putative Transporter Maps to the Osteosclerosis (oc) Mutation and Is Not Expressed in theocMutant Mouse 1999 ·Genomics ·(unknown), Holly Dushkin, (unknown), Tatsuya Koike, (unknown), Helen Her, Steven R. Gullans, Gino V. Segre, Richard M. Green, David R. Beier	67
10	Genetic analysis of modifying loci on mouse chromosome 1 that affect disease severity in a model of recessive PKD 1999 ·Physiological Genomics ·Olga A. Iakoubova, Holly Dushkin, (unknown), David R. Beier	15
11	Genetic Analysis of a Quantitative Trait in a Mouse Model of Polycystic Kidney Disease 1997 ·American Journal of Respiratory and Critical Care Medicine ·Olga A. Iakoubova, Holly Dushkin, David R. Beier	16
12	Localization of a murine recessive polycystic kidney disease mutation and modifying loci that affect disease severity 1995 ·Genomics ·Olga A. Iakoubova, Holly Dushkin, David R. Beier	54
13	Haplotype analysis of intra-specific backcross curly-tail mice confirms the localization of ct to Chromosome 4 1995 ·Mammalian Genome ·David R. Beier, Holly Dushkin, (unknown)	16
14	CD19 maps to a region of conservation between human chromosome 16 and mouse chromosome 7 1994 ·Immunogenetics ·(unknown), Susanne Edelhoff, Holly Dushkin, (unknown), (unknown), Christine M. Distèche, (unknown)	2
15	Chromosomal Localization of the Gonadotropin-Releasing Hormone Receptor Gene to Human Chromosome 4q13.1-q21.1 and Mouse Chromosome 5 1994 ·Genomics ·Ursula B. Kaiser, Holly Dushkin, Michael R. Altherr, David R. Beier, William W. Chin	26
16	Somatostatin inhibition of gastrin gene expression: involvement of pertussis toxin-sensitive and -insensitive pathways 1992 ·Regulatory Peptides ·Pratima Karnik, Holly Dushkin, M. Michael Wolfe	9
17	Mapping genes in the mouse using single-strand conformation polymorphism analysis of recombinant inbred strains and interspecific crosses. 1992 ·Proceedings of the National Academy of Sciences ·David R. Beier, Holly Dushkin, Daniel J. Sussman	66
18	Peripheral serotonin administration selectively reduces fat intake in rats 1988 ·Pharmacology Biochemistry and Behavior ·Robin B. Kanarek, Holly Dushkin	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact